Ravata Solutions

Embryo Gene Editing


        Ravata's technology delivers gene-editing agents like CRISPR into the embryos of mice. Unlike bulk-electroporators, the RIZE targets sub-portions of an embryo's membrane to maximize delivery efficiency and cell viability. At peak performance a 47% cost reduction and 50% reduction of animals used in mouse-model production has been demonstrated.



Ravata Individual Zygote Electroporator

  • Capture and Deliver Reagent to Many Zygotes in Parallel

  • Target Sub-Sections of the Membrane to Maximize Delivery

  • More than 80% CRISPR KO Efficiency and Viability 

  • Fully Automated Processes with GUI Control


Our Team


Arshia Firouzi (CoFounder, CEO)

          Arshia is the co-founder and CEO of Ravata Solutions. A UC Davis Electrical Engineering alumnus, he has a diverse range of experiences having developed software and hardware for HVAC sensor systems, assisted in deep-space gravitational lensing research, and analyzing bio-membrane acid filtration. When Arshia finds free time he enjoys playing golf, tinkering with IoT devices, and backpacking.


Gurkern Sufi (CoFounder, COO)

          Gurkern Sufi is the co-founder and COO at Ravata Solutions. He is a graduate of UC Davis’ Biotechnology program and has previously worked on projects ranging from evaluating therapeutic effectiveness for infantile necrotizing enterocolitis treatments in non-human primate models and performing clinical analysis on the effects of cardiac ablation as a treatment for atrial fibrillation to quantifying seasonal effects on biosynthesis of metabolites in Walnuts. Recreationally Gurkern enjoys participating in his adult soccer league, cycling, and experimenting with creative culinary creations.

In The News